The TLR pathway is hyperactive in mantle cell lymphoma and diffuse large B-cell lymphoma (DLBCL), and activation of NF-κB promotes B-cell survival and proliferation [39,40,41]. Here, NFKB1 is linked to diffuse large B-cell lymphoma.